💊 US FDA approvals galore; An end for many partnerships; Thinking about India’s Union budgetVinodFeb 01, 2022∙ PaidShareWelcome to February 2022.Today’s issue is brought to you by AI + ML. Or is it? This post is for paid subscribersAlready a paid subscriber? Sign inPreviousNext